FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
STAMFORD, CT -- Philip Morris International Inc. (NYSE: PM) today announces that the U.S.
Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant.
Additional 11mg variants remain under scientific review.
Read More
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.
